February DCI Seminar Series (2.24.21)
The February DCI Seminar Series, to be held on Wednesday, Feb. 24, will feature Ryan B. Corcoran, MD, PhD, director of the Gastrointestinal Cancer Center Program and the scientific director of the Termeer Center for Targeted Therapy at Massachusetts General Hospital Cancer Center.
The title of his talk is “Overcoming therapeutic resistance in GI cancers.”
Corcoran, who is also an associate professor of Medicine at Harvard Medical School, directs a research laboratory focused on personalized cancer medicine. His work, in particular, focuses on the molecular determinants of response or resistance to anti-cancer therapies.
Corcoran is a member of the National Cancer Institute Colorectal Cancer Task Force and the Rectal Cancer Task Force, and an elected member of the American Society for Clinical Investigation (ASCI).
Corcoran received his A.B. from Princeton University, and his MD/PhD from Stanford University. He completed his residency in Internal Medicine at Massachusetts General Hospital and his fellowship in Medical Oncology at the Dana Faber Cancer Institute and Massachusetts General Hospital Cancer Center.
Corcoran's lecture begins at 8 a.m. and ends at 9 a.m. The February DCI Seminar Series is presented by Duke Cancer Institute's Precision Cancer Medicine and Investigational Therapeutics (PCMIT) Research Program, and held in conjunction with Hematology Oncology Grand Rounds.
For more information and to access the Webex link, email Joan Lofton, MBA, AGM.